batirtze-areitio Batirtze Areitio Batirtze has over 5 years of experience in the biopharma and biotech industries. She joined ApexOnco in 2025 after working as an analyst at OncologyPipeline. She is a graduate of the University of Navarra, where she earned a degree in biochemistry. Astra accelerates as Acerand enters the PARP1 race 26 April 2024 Another sellside call for PD-(L)1 price competition 25 April 2024 A second attempt at heating up Anktiva 25 April 2024 Anktiva’s tortuous journey ends 23 April 2024 No Swiss surprise for Surface’s former owners 23 April 2024 Pluvicto miss puts pressure on PSMAfore expansion 23 April 2024 Carvykti joins Abecma in EU expansion 22 April 2024 Alecensa gets its first-mover adjuvant label 19 April 2024 Load More